Mirum Pharmaceuticals, Inc.: Mirum Pharmaceuticals to Showcase LIVMARLI (maralixibat) Data at EASL and ESPGHAN Annual Congresses
Eight abstracts accepted, including three oral presentations Maralixibat data highlighting predictors of event-free survival in patients with Alagille syndrome nominated for prestigious Alex Mowat
Source: finanznachrichten.de